The global apheresis market is witnessing significant growth as healthcare systems worldwide increasingly rely on advanced blood separation technologies for therapeutic treatments, plasma collection, and cellular therapies. Rising cases of chronic diseases, autoimmune disorders, hematological conditions, and neurological diseases are driving demand for apheresis procedures that enable targeted removal or collection of specific blood components.
The global apheresis market is projected to grow from USD 3.02 billion in 2026 to USD 4.41 billion by 2031, expanding at a CAGR of 7.9% during the forecast period. The market was valued at USD 2.81 billion in 2025.
Growth in the market is fueled by increasing demand for plasma-derived therapies, rising blood component requirements, advancements in blood processing technologies, expansion of plasma collection centers, and growing adoption of automated apheresis systems.
Apheresis has become an essential procedure in modern healthcare by enabling selective separation, collection, or removal of blood components such as plasma, platelets, red blood cells, and white blood cells.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950
Rising Demand for Apheresis Procedures in Modern Healthcare
Apheresis technology plays a critical role in treating several medical conditions by allowing clinicians to selectively manipulate blood components. Unlike traditional blood processing methods, apheresis enables targeted therapy while returning the remaining components back to the patient or donor.
The increasing burden of diseases requiring extracorporeal blood treatment is one of the primary factors accelerating the apheresis market growth.
Major applications include:
- Autoimmune disorder treatment
- Hematological disease management
- Neurological disorder therapies
- Plasma collection
- Stem cell collection
- Cellular therapy applications
The growing prevalence of diseases such as immune-mediated disorders, kidney diseases, and blood-related conditions has increased the demand for therapeutic apheresis procedures globally.
Increasing Demand for Plasma-Based Therapies Driving Market Expansion
One of the strongest growth drivers for the apheresis market is the rising demand for plasma-derived products.
Plasma is an important raw material used in the development of:
- Immunoglobulins
- Albumin therapies
- Coagulation factors
- Other plasma-based medicines
The increasing use of these therapies for chronic and rare diseases has created a need for efficient plasma collection systems.
Donor apheresis procedures allow collection of higher volumes of plasma compared with traditional blood donation methods, making them essential for meeting global plasma supply requirements.
Additionally, increasing awareness regarding voluntary blood donation programs and government initiatives supporting blood collection activities are contributing to market growth.
Technological Advancements Transforming Apheresis Procedures
Continuous innovation in apheresis technology is improving the efficiency, safety, and convenience of blood separation procedures.
Modern systems now incorporate:
- Automated blood separation processes
- Continuous-flow centrifugation technology
- Advanced membrane filtration methods
- Real-time monitoring systems
- Improved safety controls
These innovations help healthcare providers achieve better collection accuracy, reduce procedure time, and enhance patient comfort.
The integration of digital technologies and automated systems is also improving workflow efficiency in hospitals, blood banks, and plasma centers.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=950
Donor Apheresis Segment Expected to Register Strong Growth
Based on type, the apheresis market is segmented into:
- Donor apheresis
- Therapeutic apheresis
The donor apheresis segment is expected to grow at a significant rate during the forecast period.
The growth of this segment is attributed to increasing demand for blood components and plasma products worldwide.
Donor apheresis enables the efficient collection of specific blood components while allowing the remaining components to return to the donor.
Key factors supporting segment growth include:
- Increasing plasma demand
- Growth of plasma collection centers
- Rising awareness of blood donation
- Expansion of biopharmaceutical applications
As plasma-derived therapies become more widely used, donor apheresis will continue to gain importance.
Centrifugation Technology Dominating the Market
Based on technology, the apheresis market is categorized into:
- Centrifugation
- Membrane filtration
The centrifugation segment accounted for the largest market share due to its widespread adoption and effectiveness in separating blood components.
Centrifugation technology uses differences in density to separate plasma, platelets, red blood cells, and other components.
Advantages driving its adoption include:
- High processing efficiency
- Ability to handle large blood volumes
- Accurate component separation
- Broad use in hospitals and blood centers
Centrifugation-based systems are extensively used in both donor and therapeutic apheresis procedures.
Plasmapheresis Emerging as the Fastest-Growing Procedure Segment
By procedure, the apheresis market includes:
- Plasmapheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Other procedures
The plasmapheresis segment is projected to grow at the highest rate during the forecast period.
Plasmapheresis involves removing plasma from blood and replacing it with appropriate fluids or donor plasma when required.
The increasing prevalence of conditions requiring plasma exchange is driving demand, including:
- Autoimmune diseases
- Neurological disorders
- Hematological conditions
- Renal disorders
The growing use of plasma components for manufacturing immunoglobulin, albumin, and clotting factors is further strengthening segment growth.
Expansion of Plasma Centers Supporting Market Growth
The establishment of plasma donation centers worldwide is creating new opportunities for the apheresis market.
Healthcare organizations and biotechnology companies are investing in plasma collection infrastructure to address increasing demand for plasma-derived therapies.
These centers rely on advanced apheresis systems to improve:
- Collection efficiency
- Donor safety
- Plasma quality
- Processing capacity
Strategic collaborations between medical device manufacturers and healthcare providers are further accelerating market development.
North America Leading the Global Apheresis Market
Geographically, the apheresis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America holds the leading position in the global apheresis market due to advanced healthcare infrastructure, high adoption of automated technologies, and the presence of major plasma collection and medical device companies.
Key factors supporting regional dominance include:
- Strong demand for plasma therapies
- Well-established blood donation systems
- High healthcare expenditure
- Early adoption of advanced medical technologies
The region continues to invest in improving blood processing capabilities and expanding plasma collection networks.
Meanwhile, Asia Pacific is expected to witness the fastest growth due to increasing healthcare investments, expanding medical infrastructure, and rising awareness about blood donation and plasma therapies.
Countries such as China and India are experiencing rapid healthcare transformation, creating new opportunities for apheresis technology adoption.
Competitive Landscape of the Apheresis Market
The global apheresis market is highly competitive, with companies focusing on product innovation, partnerships, and expansion strategies.
Major players include Terumo Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical, Becton Dickinson and Company, Miltenyi Biotec, Therakos, Toray Industries, and B. Braun SE.
These companies are investing in next-generation apheresis systems, improved blood collection technologies, and solutions supporting cellular and gene therapies.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=950
Future Outlook of the Apheresis Market
The future of the apheresis market is closely connected with advancements in blood processing, regenerative medicine, and personalized therapies.
Future trends expected to shape the market include:
- Growth of plasma-based treatments
- Expansion of cellular therapy applications
- Development of automated apheresis platforms
- Increasing adoption in emerging economies
- Integration of digital monitoring technologies
As healthcare providers continue focusing on precision treatments and advanced blood therapies, apheresis will remain a critical technology supporting modern medicine. With rising disease burden, increasing plasma demand, and continuous technological innovation, the global apheresis market is positioned for sustained growth through 2031.
